SAN FRANCISCO – DecisionView, Inc., the leading provider of business performance optimization applications for the Life Sciences industry, today announced the close of its Series D investment with Granite Ventures, Adobe Ventures and Aeris Capital.
"The continued confidence demonstrated by our venture capital partners - Granite Ventures, Adobe Ventures and Aeris Capital, further validates DecisionView’s business strategy and growth opportunity,” said Steve Andrade, CEO of DecisionView. “Their investment in DecisionView, especially during this dynamic global economic period, allows us to continue to remain acutely focused on our business strategy and deliver innovative solutions and value to the life sciences industry.”
The additional funding will be applied to DecisionView’s strategic growth opportunities for expanding its distinctive platform for improving the performance of clinical trials. This includes the Company’s flagship application, StudyOptimizer, the first Web-based clinical trial enrollment software that enables companies to optimize the clinical trial recruitment and enrollment process for greater predictability, faster cycle times and reduced costs.
“DecisionView’s software continues to make a positive and significant impact on the way life sciences companies approach their clinical studies,” said Chris Hollenbeck, managing director, Granite Ventures. “With the increased economic and operational pressures on pharmaceutical companies today, DecisionView is poised for significant growth with product offerings that provide tangible value.”
“DecisionView is bringing truly unique applications to the clinical trial market and this financing will allow the company to continue to expand on their innovative offerings,” said David Hartford, managing director at Aeris Capital."
Recently, DecisionView announced several new features and enhancements to StudyOptimizer 4.0 including an innovative user interface framework, new analytic engine, an enterprise-class J2EE server and enhanced administration capabilities. Under development for more than a year, StudyOptimizer 4.0 represented a major milestone for DecisionView with new features designed to improve user experience, performance, scalability and reliability.
